Repligen (RGEN) Tops Q1 EPS by 4c, provides guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $140.92 -0.38%
Revenue Growth %: +10.7%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
EPAC, SAR, KRUS, More
Revenue Growth %: +10.7%
Financial Fact:
Research and development: 1.89M
Today's EPS Names:
EPAC, SAR, KRUS, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q1 EPS of $0.39, $0.04 better than the analyst estimate of $0.35. Revenue for the quarter came in at $169 million versus the consensus estimate of $163.4 million.
GUIDANCE:
Repligen sees FY2025 EPS of $1.63-$1.72, versus the consensus of $1.71.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TRNR agrees to acquire STEPR, raises 2026 revenue guidance to $50M
- Columbia Financial launches public stock offering at $10 per share
- UK Navy: tanker in Hormuz struck by unknown UAV, sustains minor damage
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
